ArticleInvestigative ophthalmology & visual science2026
Insulin Induces Outer Blood-Retinal Barrier Disruption via Downregulation of Claudin-19.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Purpose: Diabetic retinopathy is a common complication of diabetes mellitus, a disease that is reaching epidemic proportions worldwide. Although diabetic macular edema has generally been attributed to breakdown of the inner blood-retinal barrier, accumulating evidence suggests that the outer blood-retinal barrier (oBRB) may also be involved. Clinical studies have shown that acute intensive insulin therapy causes a transient worsening of diabetic retinopathy in type 1 and type 2 diabetes. In this study, we tested the hypothesis that insulin directly disrupts the oBRB by targeting claudin-19 tight junctions in the retinal pigment epithelium (RPE). Methods: The effects of insulin on claudin-19 tight junctions in primary RPE cells were assessed by immunohistochemistry and western blot analysis using in vitro cell culture models and an in vivo transgenic zebrafish model. Changes in blood-retinal barrier integrity were quantified using electric cell-substrate impedance sensing (ECIS). Results: Claudin-19 was identified as the predominant claudin in primary porcine RPE cells and was essential for maintaining oBRB integrity. Barrier function did not differ between RPE cells cultured under physiological (5 mM) or high (25 mM; diabetic) glucose conditions. In contrast, insulin treatment disrupted the oBRB independently of glucose concentration. Insulin significantly reduced claudin-19 protein levels without affecting transcript abundance, indicating post-transcriptional regulation. Consistent with the in vitro findings, insulin induced claudin-19 tight junction disruption in vivo in a transgenic zebrafish model expressing claudin-19 fused to enhanced green fluorescent protein. Consistent with the in vitro findings, high glucose alone did not disrupt claudin-19 in vivo. Conclusions: These findings demonstrate that insulin disrupts the oBRB independently of glucose concentration in both in vitro and in vivo models. This work provides new insight into the molecular mechanisms underlying early worsening of diabetic retinopathy and highlights a potential role for hyperinsulinemia in type 2 diabetes-associated retinal pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.